The CORCOBIA study: Cut-off points of Alzheimer’s disease CSF biomarkers in a clinical cohort-Reference-Cited by-同舟云学术

The CORCOBIA study: Cut-off points of Alzheimer’s disease CSF biomarkers in a clinical cohort

Published:2022-08 Issue: Volume: Page:
ISSN:2173-5808
Container-title:Neurología (English Edition)
language:en
Short-container-title:Neurología (English Edition)

Author:

Puig-Pijoan A.,García-Escobar G.,Fernández-Lebrero A.,Manero-Borràs R.M.,Sánchez-Benavides G.,Navalpotro-Gómez I.,Cascales Lahoz D.,Suárez-Calvet M.,Grau-Rivera O.,Boltes Alandí A.,Pont-Sunyer M.C.,Ortiz-Gil J.,Carrillo-Molina S.,López-Villegas D.,Abellán-Vidal M.T.,Martínez-Casamitjana M.I.,Hernández-Sánchez J.J.,Peña-Casanova J.,Roquer J.,Padrós Fluvià A.,Puente-Périz V.

Publisher

Elsevier BV

Subject

General Materials Science

Reference49 articles.

1. Appropriate use criteria for lumbar puncture and cerebrospinal fluid testing in the diagnosis of Alzheimer’s disease;Shaw;Alzheimers Dement.,2018

2. Biomarcadores en la enfermedad de Alzheimer;Amer,2018

3. The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease;Albert;Alzheimers Dement.,2011

4. The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease;McKhann;Alzheimers Dement.,2011

5. Guies clíniques d’ús de biomarcadors de malaltia d’Alzheimer en el líquid cefalorraquidi en l’avaluació de pacients amb deteriorament cognitiu;Balasa,2015

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biomarker Discovery in Alzheimer’s and Neurodegenerative Diseases using Nucleic Acid-Linked Immuno-Sandwich Assay;2024-07-29

2. Time‐encoded ASL reveals lower cerebral blood flow in the early AD continuum;Alzheimer's & Dementia;2024-07-03

3. Risk of cognitive decline progression is associated to increased blood‐brain‐barrier permeability: A longitudinal study in a memory unit clinical cohort;Alzheimer's & Dementia;2023-09-19

4. A how-to guide for a precision medicine approach to the diagnosis and treatment of Alzheimer's disease;Frontiers in Aging Neuroscience;2023-08-17

5. NEURONORMA Cognitive Battery Associations with Cerebrospinal Fluid Amyloid-β and Tau Levels in the Continuum of Alzheimer’s Disease;Journal of Alzheimer's Disease;2023-04-18